• Home
  • » 
  • Reports
  • » 
  • SARM1 Inhibitors Market by Target Indica...

SARM1 Inhibitors Market

SARM1 Inhibitors Market by Target Indications (Multiple Sclerosis, Peripheral, Central and Ocular Nervous System Disorders, Peripheral Neuropathies, Glaucoma and Amyotrophic Lateral Sclerosis), Type of Molecules (Small Molecules and Biologics), Drug Developers, Drug Candidates and Key Geographies (North America and Europe): Industry Trends and Global Forecasts, 2022-2040

  • Lowest Price Guaranteed From USD 5,899

  • Published
    November 2022

  • Slides
    90

  • View Count
    2012

  • Buy Now
Request Sample Pages

PRICING DETAILS

USD 5,899

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license grants the right of use of the purchased report by a department / team of individuals (up to 12) in a particular organization. The license does not limit the use to a particular site / office location. The report may be accessed on the computer read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases
sales@rootsanalysis.com

This site uses cookies for better browsing experience  Accept

Copyright © 2023 Roots Analysis. All Rights Reserved.